Seven Dogs, No Ventilators: sPLA2 Inhibitor Shows Promise in Coral Snake Bites

Seven dogs with severe eastern coral snake envenomation recovered without mechanical ventilation after receiving antivenom plus an investigational phospholipase A2 inhibitor — four treated intravenously, three orally — with substantial reductions in hospital stay length and cost of care compared with historical controls. Those seven cases, reported by Michael Schaer, DVM, Diplomate ACVIM and ACVECC, professor emeritus at the University of Florida College of Veterinary Medicine, and Timothy F. Platts-Mills, MD, MSc, chief medical officer at Ophirex, Inc., mark the leading edge of a therapy that remains experimental — while antivenom keeps its place as the only specific treatment for clinically significant envenomation in dogs.

Which snakes bite dogs, and what does the venom do?

Pit vipers (family Crotalidae) — rattlesnakes, copperheads, and cottonmouths — account for most venomous snakebites in North American dogs. The animals' outdoor activity and curiosity put them at disproportionate risk; most bites involve the face, neck, or front legs.

Venom composition varies between species and even within a species by geography, age, and season. Classically described as cytotoxic and hemotoxic, pit viper venom causes:

• local tissue destruction and edema
• hemorrhage and endothelial injury
• thrombocytopenia and coagulopathy
• myonecrosis and rhabdomyolysis
• hypotension and shock

Some populations — Mojave rattlesnakes and certain timber rattlesnakes — carry clinically important neurotoxicity, so the absence of local findings can delay recognition of severe envenomation.

What changes at the exam table?

Stabilization outranks species identification. Owners should photograph the snake rather than handle it, because reflex envenomation can occur after death. Prehospital advice: restrict activity, transport immediately, and avoid tourniquets, incisions, suction, ice packs, and electric shock — none has demonstrated benefit and each may worsen tissue injury.

Despite dramatic swelling, facial bites rarely compromise the airway in dogs; stertorous breathing or elevated PCO2 signals the rare exception requiring oxygen or advanced airway management. Severity of local swelling does not predict systemic toxicity.

Baseline diagnostics include CBC with platelet count, blood smear, biochemistry, coagulation testing, urinalysis, and blood gas analysis when neurotoxicity threatens hypoventilation. Echinocytosis has appeared in a high proportion of pit viper and coral snake cases. Clinicians should track hypofibrinogenemia, hemolysis, pigmenturia — both myoglobin and hemoglobin are nephrotoxic — acute kidney injury, and rising creatine kinase, because coagulopathy and hemolysis may develop hours after presentation.

How should antivenom be given?

Indications include progressive swelling, hypotension or shock, coagulopathy, hemolysis, neurotoxicity, significant pain, and rapid progression. Delay of several hours worsens outcomes, possibly because venom has already distributed into tissue. Dose depends on venom load, not body size — small dogs may need as many vials as large dogs.

Administer intravenously with slow initial rates and epinephrine (0.01 mg/kg IM) immediately available; true anaphylaxis is uncommon, with higher rates reported for whole IgG than F(ab')2 products. The authors do not recommend antihistamine pretreatment.

What supportive care and controversies remain?

IV crystalloids anchor management; hetastarch is not recommended because it impairs platelets. Blood products are rarely indicated in the first 18–24 hours. Opioids control pain; NSAIDs are avoided for platelet and renal-perfusion effects. Routine corticosteroids and prophylactic antibiotics are generally not recommended, though secondary infection, when it occurs, is usually evident by the third hospital day.

Coral snakes present a distinct problem: elapid neurotoxin can cause progressive lower motor neuron paralysis, respiratory failure, and hemolysis in approximately 40 percent of dogs, sometimes with an initially asymptomatic patient. Antivenom may not reverse established neuromuscular weakness, so intensive support and days of ventilation may follow.

What is next?

Most dogs treated promptly for pit viper envenomation survive, and extensive necrosis often heals over 12–16 weeks without surgery. Larger comparative studies must now test whether phospholipase A2 inhibition — building on the JAVMA report of the first three dogs — improves outcomes beyond antivenom-based care, including in crotalid envenomation.